Is Abiomed Stock a Buy?
Abiomed (NASDAQ: ABMD) struggled in 2019, but the stock has risen more than 62% so far this year. Abiomed's devices all have to do with the circulatory system, including the world's smallest heart pump, the Impella. Since the company acquired the Impella technology by buying German company Impella CardioSystems in 2005, Abiomed's revenue has risen every year.